Select Publications
Journal articles
2020, 'Identifying incident cancer cases in dispensing claims: A validation study using Australia's Repatriation Pharmaceutical Benefits Scheme (PBS) data', International Journal of Population Data Science, 5, http://dx.doi.org/10.23889/ijpds.v5i1.1152
,2020, 'Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)', PLoS ONE, 15, pp. e0230373, http://dx.doi.org/10.1371/journal.pone.0230373
,2020, 'Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016', Therapeutic Advances in Gastroenterology, 13, http://dx.doi.org/10.1177/1756284820913743
,2020, '730 Exploration of Single Antiplatelet Drug use in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Cardiac Stenting', Heart, Lung and Circulation, 29, pp. S364 - S365, http://dx.doi.org/10.1016/j.hlc.2020.09.737
,2020, 'Medicine reviews: do they reduce benzodiazepine use in older Australians?', Public Health Research & Practice, 31, http://dx.doi.org/10.17061/phrp30452015
,2019, 'Exercise trials for blood pressure control: Keeping it REAL', British Journal of Sports Medicine, 53, pp. 1443 - 1444, http://dx.doi.org/10.1136/bjsports-2019-100787
,2019, 'Prescription opioid dispensing in Australian children and adolescents: a national population-based study', The Lancet Child and Adolescent Health, 3, pp. 881 - 888, http://dx.doi.org/10.1016/S2352-4642(19)30329-3
,2019, 'Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)', British Journal of Cancer, 121, pp. 904 - 911, http://dx.doi.org/10.1038/s41416-019-0612-5
,2019, 'Risk of Ectopic Pregnancy and Tubal Infertility Following Gonorrhea and Chlamydia Infections', Clinical Infectious Diseases, 69, pp. 1621 - 1623, http://dx.doi.org/10.1093/cid/ciz145
,2019, 'Patterns of immediate breast reconstruction in New South Wales, Australia: a population-based study', ANZ Journal of Surgery, 89, pp. 1230 - 1235, http://dx.doi.org/10.1111/ans.15381
,2019, 'Comparison of Prescribing Patterns before and after Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia', JAMA Network Open, 2, pp. e1911590, http://dx.doi.org/10.1001/jamanetworkopen.2019.11590
,2019, 'Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015)', BMC Cancer, 19, pp. 909, http://dx.doi.org/10.1186/s12885-019-6126-y
,2019, 'Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 61, pp. 1 - 7, http://dx.doi.org/10.1016/j.canep.2019.05.001
,2019, 'Protocol for the Data-Linkage Alcohol Cohort Study (DACS): Investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2019-030605
,2019, 'Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0221480
,2019, 'Polypharmacy among older Australians, 2006–2017: a population-based study', Medical Journal of Australia, 211, pp. 71 - 75, http://dx.doi.org/10.5694/mja2.50244
,2019, 'Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 60, pp. 156 - 161, http://dx.doi.org/10.1016/j.canep.2019.04.004
,2019, 'Embracing the full spectrum of real-world data for cancer medicines research in Australia', Asia-Pacific Journal of Clinical Oncology, 15, pp. 186 - 187, http://dx.doi.org/10.1111/ajco.13121
,2019, 'Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients', Pharmacoepidemiology and Drug Safety, 28, pp. 812 - 820, http://dx.doi.org/10.1002/pds.4751
,2019, 'Exploring variation in low-value care: A multilevel modelling study', BMC Health Services Research, 19, http://dx.doi.org/10.1186/s12913-019-4159-1
,2019, 'Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics', Australian & New Zealand Journal of Psychiatry, 53, pp. 000486741984776 - 000486741984776, http://dx.doi.org/10.1177/0004867419847764
,2019, 'Health-related quality of life among HIV-infected patients initiating treatment in Brazil in the single-tablet regimen era', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 31, pp. 572 - 581, http://dx.doi.org/10.1080/09540121.2019.1576841
,2019, 'Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate', Pharmacoepidemiology and Drug Safety, 28, pp. 521 - 527, http://dx.doi.org/10.1002/pds.4755
,2019, 'Measuring Hospital-Acquired Complications Associated with Low-Value Care', JAMA Internal Medicine, 179, pp. 499 - 505, http://dx.doi.org/10.1001/jamainternmed.2018.7464
,2019, 'A population-based study of transdermal fentanyl initiation in Australian clinical practice', European Journal of Clinical Pharmacology, 75, pp. 401 - 408, http://dx.doi.org/10.1007/s00228-018-2588-0
,2019, 'Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations', Addiction, 114, pp. 404 - 405, http://dx.doi.org/10.1111/add.14556
,2019, 'Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)—in reply', Addiction, 114, pp. 572 - 573, http://dx.doi.org/10.1111/add.14531
,2019, 'Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting', Addiction, 114, pp. 389 - 399, http://dx.doi.org/10.1111/add.14380
,2019, 'Response to: A 'Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia' by Morton and Thompson', BMJ Quality and Safety, 28, pp. 255 - 256, http://dx.doi.org/10.1136/bmjqs-2018-009213
,2019, 'Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: A population-based health record linkage study protocol', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-026414
,2019, 'Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: A prospective cohort investigation among adults aged 45 years and over in Australia', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-027305
,2019, 'Trends in self-poisoning and psychotropic drug use in people aged 5-19 years: A population-based retrospective cohort study in Australia', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-026001
,2019, 'Anticholinergic medicines use among older adults before and after initiating dementia medicines', British Journal of Clinical Pharmacology, 85, pp. 1957 - 1963, http://dx.doi.org/10.1111/bcp.13976
,2019, 'Evidence-practice gaps in postdischarge initiation with oral anticoagulants in patients with atrial fibrillation', Journal of the American Heart Association, 8, pp. e014287, http://dx.doi.org/10.1161/JAHA.119.014287
,2019, 'Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study', Pharmacoepidemiology and Drug Safety, 28, pp. 97 - 105, http://dx.doi.org/10.1002/pds.4683
,2019, 'Measuring 21 low-value health care procedures in Australian private health insurance claims data (2010 – 2014)', BMJ
,2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, 210, http://dx.doi.org/10.5694/mja2.12047
,2018, 'Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia', BMC Health Services Research, 18, pp. 1009, http://dx.doi.org/10.1186/s12913-018-3811-5
,2018, 'Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants', PLoS ONE, 13, pp. e0208824, http://dx.doi.org/10.1371/journal.pone.0208824
,2018, 'Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2018-025840
,2018, 'Current Opioid Access, Use, and Problems in Australasian Jurisdictions', Current Addiction Reports, 5, pp. 464 - 472, http://dx.doi.org/10.1007/s40429-018-0227-6
,2018, 'Access to routinely collected data for population health research: experiences in Canada and Australia', Australian and New Zealand Journal of Public Health, 42, pp. 430 - 433, http://dx.doi.org/10.1111/1753-6405.12813
,2018, 'Needs and priority areas for building capacity for working with linked data in the Australian pharmacoepidemiology workforce', International Journal of Population Data Science, 3, http://dx.doi.org/10.23889/ijpds.v3i4.733
,2018, 'Rising pregabalin use and misuse in Australia: trends in utilisation and intentional poisonings', Addiction, 114, pp. 1026 - 1034, http://dx.doi.org/10.1111/add.14412
,2018, 'Accidental pharmacological poisonings in young children: population-based study in three settings', Clinical Toxicology, 56, pp. 782 - 789, http://dx.doi.org/10.1080/15563650.2017.1422509
,2018, 'Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016)', Breast Cancer Research and Treatment, 171, pp. 151 - 159, http://dx.doi.org/10.1007/s10549-018-4804-0
,2018, 'Adherence to prescribing restrictions for her2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)', PLoS ONE, 13, http://dx.doi.org/10.1371/journal.pone.0198152
,2018, 'The GUIDES checklist: Development of a tool to improve the successful use of guideline-based computerised clinical decision support', Implementation Science, 13, http://dx.doi.org/10.1186/s13012-018-0772-3
,2018, 'Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016', Journal of the American Geriatrics Society, 66, pp. 1180 - 1185, http://dx.doi.org/10.1111/jgs.15292
,2018, 'Cardiovascular toxicity of targeted therapies for cancer: A protocol for an overview of systematic reviews', BMJ Open, 8, pp. e021064, http://dx.doi.org/10.1136/bmjopen-2017-021064
,